Anavex Life Sciences (AVXL) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Anavex Life Sciences (AVXL) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 8, 2023 (06:23)

Sector: Healthcare

The share price of Anavex Life Sciences Corp. (AVXL) now

Latest session on the 7th of December for
Anavex Life Sciences Corp. is positive
Trading Volume: 815007
Open: 8.02 /  High: 8.19 /  Low: 7.92
What analysts predict: $47.75
52-week High/Low: $11.93 / $4.9

50/200 Day Moving Average: $6.22 / $7.94

This figure corresponds to the Average Price over the previous 50/200 days. For Anavex Life Sciences stocks, the 50-day moving average is the support level today.

For Anavex Life Sciences stocks, the 200-day moving average is the support level today.

Are you interested in Anavex Life Sciences Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Anavex Life Sciences stock price in 2024, 2025, 2026, 2027, 2028. How much will one Anavex Life Sciences share be worth in 2024 - 2028?

When should I take profit in Anavex Life Sciences stock? When should I record a loss on Anavex Life Sciences stock? What are analysts' forecasts for Anavex Life Sciences stock? What is the future of Anavex Life Sciences stock? We forecast Anavex Life Sciences stock performance using neural networks based on historical data on Anavex Life Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Anavex Life Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Anavex Life Sciences shares. This happens once a day.




Historical and forecast chart of Anavex Life Sciences stock

The chart below shows the historical price of Anavex Life Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Anavex Life Sciences stock price can be found in the table below.

Long-term forecasts by years.

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, is developing drug candidates for the treatment of diseases of the central nervous system (CNS).

Anavex Life Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 10 8.09 7.93 8.35 5.27
Dec 11 8.12 7.80 8.33 6.75
Dec 12 8.32 8.05 8.60 6.82
Dec 13 8.30 8.03 8.45 5.17
Dec 14 8.65 8.35 8.81 5.53
Dec 15 8.59 8.32 8.91 7.10
Dec 16 8.75 8.58 8.91 3.81
Dec 17 8.98 8.65 9.28 7.31
Dec 18 8.69 8.47 8.93 5.42
Dec 19 8.67 8.42 8.92 5.94
Dec 20 8.53 8.31 8.65 4.06
Dec 21 8.29 8.14 8.44 3.70
Dec 22 8.10 7.76 8.40 8.27
Dec 23 8.15 7.92 8.41 6.17
Dec 24 8.13 7.86 8.28 5.29
Dec 25 8.23 8.05 8.60 6.75
Dec 26 8.56 8.24 8.72 5.77
Dec 27 8.85 8.64 9.24 6.99
Dec 28 8.67 8.30 8.80 6.09
Dec 29 8.79 8.61 9.12 5.89
Dec 30 8.69 8.59 8.92 3.84
Dec 31 8.26 8.04 8.44 4.97
Jan 01 8.05 7.92 8.23 3.91
Jan 02 8.20 7.88 8.30 5.26
Jan 03 8.20 7.90 8.37 6.00
Jan 04 8.33 8.21 8.55 4.13
Jan 05 8.15 8.01 8.51 6.27
Jan 06 7.88 7.55 7.97 5.57
Jan 07 8.03 7.84 8.20 4.56
Jan 08 7.94 7.72 8.26 6.96

Anavex Life Sciences Daily Price Targets


Anavex Life Sciences Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $8.09.
Negative dynamics for Anavex Life Sciences shares will prevail with possible volatility of 5.010%.
Pessimistic target level: 7.93
Optimistic target level: 8.35

Anavex Life Sciences Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $8.12.
Positive dynamics for Anavex Life Sciences shares will prevail with possible volatility of 6.323%.
Pessimistic target level: 7.80
Optimistic target level: 8.33

Anavex Life Sciences Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $8.32.
Positive dynamics for Anavex Life Sciences shares will prevail with possible volatility of 6.386%.
Pessimistic target level: 8.05
Optimistic target level: 8.60

Anavex Life Sciences Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $8.30.
Negative dynamics for Anavex Life Sciences shares will prevail with possible volatility of 4.916%.
Pessimistic target level: 8.03
Optimistic target level: 8.45

Anavex Life Sciences Stock Forecast 12-14-2023.

Forecast target price for 12-14-2023: $8.65.
Positive dynamics for Anavex Life Sciences shares will prevail with possible volatility of 5.240%.
Pessimistic target level: 8.35
Optimistic target level: 8.81

Anavex Life Sciences Stock Forecast 12-15-2023.

Forecast target price for 12-15-2023: $8.59.
Negative dynamics for Anavex Life Sciences shares will prevail with possible volatility of 6.631%.
Pessimistic target level: 8.32
Optimistic target level: 8.91

AVXL (AVXL) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan. 7.74 6.96 8.91 21.88
Feb. 8.56 8.11 9.86 17.71
Mar. 8.93 8.43 9.70 13.08
Apr. 9.06 8.64 9.66 10.51
May. 7.32 6.62 8.21 19.43
Jun. 7.99 7.43 9.10 18.28
Jul. 8.65 8.08 9.98 19.06
Aug. 9.31 8.02 9.79 18.06
Sep. 9.51 9.02 10.90 17.28
Oct. 9.51 8.88 10.75 17.35
Nov. 7.93 7.28 8.34 12.74
Dec. 7.82 6.79 8.18 17.02

Anavex Life Sciences forecast for this year


Anavex Life Sciences Stock Prediction for Jan 2024

An downtrend is forecast for this month with an optimal target price of $7.73766. Pessimistic: $6.96. Optimistic: $8.91


Anavex Life Sciences Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $8.55785. Pessimistic: $8.11. Optimistic: $9.86


Anavex Life Sciences Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $8.9344. Pessimistic: $8.43. Optimistic: $9.70


Anavex Life Sciences Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $9.05948. Pessimistic: $8.64. Optimistic: $9.66


Anavex Life Sciences Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $7.32006. Pessimistic: $6.62. Optimistic: $8.21


Anavex Life Sciences Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $7.9935. Pessimistic: $7.43. Optimistic: $9.10


Anavex Life Sciences Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $8.64897. Pessimistic: $8.08. Optimistic: $9.98


Anavex Life Sciences Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $9.30629. Pessimistic: $8.02. Optimistic: $9.79


Anavex Life Sciences Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $9.51103. Pessimistic: $9.02. Optimistic: $10.90


Anavex Life Sciences Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $9.51103. Pessimistic: $8.88. Optimistic: $10.75


Anavex Life Sciences Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $7.9322. Pessimistic: $7.28. Optimistic: $8.34


Anavex Life Sciences Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $7.82115. Pessimistic: $6.79. Optimistic: $8.18



Anavex Life Sciences (AVXL) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 7.99 6.71 8.92 24.73
Feb 9.46 9.03 9.90 8.80
Mar 11.28 9.86 12.25 19.52
Apr 10.51 9.48 11.00 13.77
May 12.03 11.07 13.35 17.12
Jun 12.77 11.91 13.54 12.08
Jul 11.78 11.14 12.30 9.39
Aug 11.80 10.62 13.34 20.35
Sep 10.29 8.97 11.22 20.00
Oct 9.94 9.32 11.15 16.40
Nov 10.84 10.12 11.59 12.71
Dec 10.01 8.61 11.35 24.16

Anavex Life Sciences (AVXL) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 11.87 10.81 13.09 17.42
Feb 10.73 9.49 12.15 21.91
Mar 11.23 10.31 12.42 17.00
Apr 10.33 9.28 11.45 18.95
May 8.47 7.34 9.76 24.83
Jun 7.67 7.23 8.36 13.58
Jul 7.66 6.59 8.70 24.30
Aug 7.58 6.81 8.31 18.07
Sep 6.85 6.18 7.54 18.00
Oct 6.29 6.04 6.78 10.95
Nov 6.67 5.91 7.51 21.31
Dec 7.34 6.82 7.64 10.75

Anavex Life Sciences (AVXL) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 8.19 7.42 8.56 13.38
Feb 8.53 7.92 9.27 14.55
Mar 9.79 9.15 10.26 10.88
Apr 10.70 10.16 11.57 12.20
May 10.12 9.23 10.72 13.96
Jun 10.10 8.74 11.45 23.63
Jul 10.06 8.89 11.24 20.93
Aug 9.09 8.47 10.18 16.79
Sep 10.76 9.11 12.31 26.05
Oct 10.85 9.27 11.44 18.98
Nov 12.35 11.41 14.18 19.51
Dec 13.04 12.41 14.68 15.45

Anavex Life Sciences (AVXL) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 14.29 12.18 14.86 18.08
Feb 14.78 14.04 16.05 12.52
Mar 13.89 12.61 15.84 20.35
Apr 12.39 11.00 13.48 18.38
May 11.85 11.11 13.24 16.10
Jun 9.95 8.38 10.35 19.04
Jul 8.99 8.58 9.86 12.96
Aug 9.43 8.84 10.31 14.26
Sep 10.52 9.97 11.61 14.13
Oct 12.43 11.32 14.37 21.28
Nov 13.26 11.80 14.74 19.96
Dec 14.26 12.55 15.12 16.98

Anavex Life Sciences information and performance

Anavex Life Sciences Address

51 W 52ND STREET,, 7TH FLOOR, NEW YORK, NY, US

Market Capitalization: 657 513 000 $

Market capitalization of the Anavex Life Sciences Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AVXL shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA of Anavex Life Sciences is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.6

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -10.88

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 82086000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.